Coronary Heart Disease
After adjustment for established coronary heart disease risk factors and kidney function, higher fibroblast growth factor 23 concentrations were correlated with an increased risk for coronary heart disease.
Both men and women with type 1 diabetes had similar extent of coronary artery disease when admitted for coronary angiography.
There were no significant differences for the observed 3-year rates of target vessel failure for different types of drug-eluting stents in patients with left main coronary artery disease.
In patients with diabetes who had an acute myocardial infarction, the acute-to-chronic glycemic ratio was a better predictor of mortality compared with baseline glycemia levels.
Myocardial infarction and coronary heart disease may be predicted by multibiomarker disease activity in patients with rheumatoid arthritis.
Increasing coronary artery calcium correlated with increased CVD events, whereas increasing cardiorespiratory fitness tended to correlate with decreased CVD events.
Supplementation with omega-3 fatty acids is not associated with fatal or nonfatal coronary heart disease or major vascular events.
Percutaneous coronary intervention is associated with increased rates of adverse outcomes compared with CABG in patients with 3-vessel CAD.
The pooled relative risk for coronary heart disease was 1.48 and 2.04, respectively, for smoking 1 and 20 cigarettes per day.
Patients with stable chest pain who have high-risk plaque as identified by coronary computed tomographic angiography may have a higher risk for MACE.
Diabetes and prediabetes duration are both independently associated with the presence of coronary artery calcified plaque.
The risk of mortality is increased for certain patients undergoing percutaneous coronary intervention with incomplete revascularization.
Guidelines that recommend statins for more people for primary prevention of atherosclerosis are likely to prevent more ASCVD events than guidelines that recommend fewer people take statins.
The association between sleep duration and incident diabetes may be similar to the association between sleep duration and incident coronary heart disease.
The ideal cardiovascular health score and the Fuster-BEWAT score are similar in their ability to predict subclinical atherosclerosis.
There is a decreased risk of cardiovascular disease linked with nut consumption.
No evidence shows efficacy of PCI procedures for patients with stable coronary artery disease with angina.
Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.
Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.
White males who participate in 3 times the recommended physical activity over many years have higher odds of developing coronary subclinical atherosclerosis.
A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.
Increased arterial stiffness is associated with increased incidence of diabetes.
Restrictive spirometry pattern and reduced forced vital capacity level are associated with increased risk of arterial stiffness.
For patients with cardiovascular disease, natural disasters can pose serious health dangers.
Everolimus-eluting bioresorbable vascular scaffolds are associated with increased odds of scaffold thrombosis and other thrombotic events.
Coronary artery calcium may be the best noninvasive risk marker for predicting a major cardiovascular event in patients with COPD.
For coronary heart disease patients with type 2 diabetes, combined Indian yoga and aerobic exercise is associated with greater improvement in heart disease risk factors.
Patients with severe obstructive sleep apnea may experience a decrease in carotid intima-media thickness with continuous positive airway pressure therapy.
Improvements in activity, weight, QoL for patients with coronary heart disease refusing cardiac rehab
For patients with CAD, CCTA is associated with reduced incidence of myocardial infarction but no reduction in death or hospitalization.
The Cardiology Advisor Articles
- FDA Reports Combination Hypertension Treatment Discontinued
- Automated Detection of Atrial Fibrillation Through Smartwatch Technology
- Cardiovascular Outcomes of SGLT-2i vs Other Glucose-Lowering Drugs in T2D
- Outcomes With Aspirin for Primary Prevention in Heart Failure, Type 2 Diabetes
- Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain
- Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time
- Pioglitazone Lowers Cardiovascular, Noncardiovascular Mortality in Diabetes
- Peripheral Artery Disease, DVT Risk May Increase With Varicose Veins
- Cardiorespiratory Fitness May Improve Executive Function in Mild Cognitive Impairment
- Preventing Chemotherapy-Related Cardiotoxicity in Breast Cancer
- Patent Foramen Ovale Characteristics May Predict Benefits of PFO Closure
- Low-Dose Triple Combo Therapy Effective in Hypertension
- Blood Pressure, Glucose Levels Worsened From the Great Recession
- Acute MI Hospital Mortality During Transcatheter Cardiovascular Therapeutics Meeting Dates
- A 64-Year-Old Woman With Colorectal Cancer Presents to ED With Severe Chest Pain